Navigation Links
GeneThera Extends its Reach Overseas
Date:6/16/2009

Results from Pharma Finance 2009

ARVADA, Colo., June 16 /PRNewswire-FirstCall/ -- GeneThera, Inc. (OTC: GTHR.PK). GeneThera, as a service and responsibility to our shareholders, is addressing our recent events.

GeneThera Inc. recently attended Pharma Finance 2009, a Biotechnology, Medical Devices, and world public and private Finance Conference in Rome, Italy on June 4-5.

Pharma Finance is an international event addressing new technologies for Life Sciences, concentrating on Biotechnology, finance, nano-technology and innovative materials.

The Lazio Region and Sviluppo Lazio S.p.A. jointly organized Pharma Finance, in collaboration with the Ministry for International Commerce, ICE, Filas S.p.A. and the Zangani Investor Community.

During the two-day event big pharma, small and medium size enterprises, research and university centers presented their products, research projects and technologies. The Conference foreign delegation session fostered the internationalization process taken by many businesses, to develop international cooperation; the presence of Business Angels and Venture Capitalist provided useful information to new entrepreneurial activities.

Dr. Milici comments, "We felt that this particular conference provided us the opportunity to meet with companies outside the United States, such as Canada and Italy, but also emerging nations such as The United Arab Emirates and Singapore to name a few. We feel that the safety of the world's food system can be protected by our proprietary technology, which stems from our vast expertise in creating solutions from microbiology and genetics."

As a result of the attendance at Pharma Finance 2009, GeneThera is in talks with the University of Rome, who is also working on a vaccine for Johne's disease and looking to collaborate on the activities in Mexico. In addition, GeneThera will be looking t
'/>"/>

SOURCE GeneThera, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. STC.UNM Signs License Option Agreement With GeneThera for E. coli O157:H7 Vaccine
2. [video] Dr. Tony Milici, Chairman and CEO of GeneThera, Inc., Discusses Worldwide Rights to E.Coli Vaccine on WallSt.nets 3-Minute Press Show
3. Insmed Announces That NASDAQ Further Extends Temporary Suspension of Minimum Bid Closing Price Rule
4. Endo Pharmaceuticals Extends Subsequent Offering Period for Indevus Shares Until 5:00 pm EDT on Wednesday, March 18, 2009
5. BVF Acquisition LLC Extends Avigen Tender Offer to April 3, 2009
6. BVF Acquisition LLC Extends Avigen Tender Offer to March 6, 2009
7. BioMed Realty Trust Extends Leases With Vertex Pharmaceuticals Through 2015
8. GlaxoSmithKline Reduces Minimum Tender Condition and Extends Tender Offer To Acquire Genelabs Technologies, Inc.
9. GlaxoSmithKline Extends Tender Offer for Genelabs Technologies, Inc.
10. NASDAQs Temporary Suspension of Minimum Bid Closing Price Rules Extends Insmeds Compliance Date to March 20, 2009
11. Ziehm Imaging Extends its Training Offer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... 22, 2015  Derma Sciences, Inc. (Nasdaq: ... advanced wound care, announces that AMNIOEXCEL® and AMNIOMATRIX®, ... added to the Premier, Inc. Regenerative Skin Grafting ... the AMNIOEXCEL® and AMNIOMATRIX® product lines, which continue ...
(Date:12/24/2014)...  Vermillion, Inc. (Nasdaq:   VRML), a bio-analytical solutions ... the Company closed its previously announced private placement ... W. Schuler , Birchview Fund LLC and several ... offering expenses.  The proceeds will be used for ...
(Date:12/24/2014)... December 23, 2014 Earlier this year in ... director of the Adult Stem Cell Technology Center, LLC ( ... appreciated unique property of adult tissue stem cells. His ... Past, Important for the Future,” embodied the essence of his ...
(Date:12/24/2014)... December 23, 2014 The report ... its definition, classification, application and industry overview. This ... product cost structure. Production is separated by regions, ... raw materials, equipment, downstream client survey, marketing channels, ...
Breaking Biology Technology:Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 2Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 3Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 4Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 5Vermillion Announces Closing of Equity Financing 2Vermillion Announces Closing of Equity Financing 3Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 2Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 3Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 4Worldwide Methyl Mercaptan Market 2015-2020 Forecasts on Development & Trends Now Available at ReportsnReports.com 2
... (OTCBB:MYMX) announced today that its company information ... Market Access Program, an,information distribution service that ... company information disseminated to users of,Standard & ... be made,available through this program includes share ...
... Comprehensive Clinical Picture, Improves,Patient-Physician Communications, KING ... A patients who,use Helixate(R) FS, Antihemophilic Factor ... treatment progress in real time,thanks to the ... system recently introduced by CSL Behring. The ...
... President of Commercial Operations,and James Briggs Senior Vice ... 25 Ikaria Holdings, Inc., a fully,integrated critical ... key executives. Stephen A. Ross was appointed Senior ... named Senior Vice,President for Human Relations., Daniel ...
Cached Biology Technology:Mymetics Corporation Information to be Available Through Standard & Poor's Market Access Program 2CSL Behring's Innovative HeliTrax(SM) System Helps Physicians Manage Hemophilia A Patients 2CSL Behring's Innovative HeliTrax(SM) System Helps Physicians Manage Hemophilia A Patients 3CSL Behring's Innovative HeliTrax(SM) System Helps Physicians Manage Hemophilia A Patients 4Ikaria(R) Strengthens Commercial Operations and Human Resources Leadership 2
(Date:1/22/2015)... YORK , Jan. 21, 2015  Analyst Report Issued by ... Card Brands report showed that planet-wide, transactions at merchants on ... while the total number of credit, debit, and prepaid cards ... U.S. were victims of fraudulent card usage in 2012, and ...
(Date:1/22/2015)... 22, 2015 Research and Markets ( ... "Global Wearable Technologies Market and Applications, Opportunities, ... and Forecast 2014-2020" report to their offering. ... devices that can be worn on the user,s ...
(Date:1/22/2015)... , Jan. 22, 2015 Infinisource has launched its new ... G2 model. The G2 sets a higher standard for collecting ... capital management solution. With plug-and-play installation, touch screen interface and ... provides a robust time collection solution for the small to ...
Breaking Biology News(10 mins):$4.80 Near Term Price Target with "Buy" given by CapRock Research for NXT-ID, Inc. (NASDAQ: NXTD) issued by Small Cap IR 2Global Wearable Technologies Market and Applications, Opportunities, Industry Analysis, Segmentation, Size, Growth, Share, Overview, Trends and Forecast 2014-2020 2Infinisource's NXG series sets new time clock standard 2
... Dalhousie University in Nova Scotia have identified a key ... growth if their findings are confirmed. In ... journal of the American Association for Cancer Research, lead ... Biochemistry and Molecular Biology and Pathology, and Canada Research ...
... it,s on to proteins, a much more daunting task. There ... molecules in our bodies. Many of these hold keys to ... Northwestern University chemical biologist Neil Kelleher has developed a new ... molecules quickly. Many have been skeptical that such an approach, ...
... major public symposium at Boston College will bring together four ... contributions of the physical and social sciences to a contemporary ... Liberal Arts University Why It Matters to Us All, ... the Liberal Arts, takes place today at the University,s main ...
Cached Biology News:Key driver of metastasis identified 2So many proteins, so much promise 2So many proteins, so much promise 3Science in the liberal arts university 2
Chicken polyclonal to YebU ( Abpromise for all tested applications). Antigen: Synthetic peptide, corresponding to amino acids 196-244 of E. coli YebU....
Rabbit polyclonal to Peptide E ( Abpromise for all tested applications)....
...
...
Biology Products: